Short- and Long-Term Effects of Cannabis on Headache and Migraine: Journal of Pain

Although cannabinoid-based medicine has been a common treatment for headache and migraines for some time, research has been relatedly limited up until this point. A study recently published in the Journal of Pain sheds new light to cannabinoids benefits, and the findings are quite compelling.

The study set to show whether inhalation of cannabis decreased headache and migrate ratings, as well as which type of cannabis (whether concentrated in oil form or in dried flower form) was proven to be most effective.

The findings showed that headache and migraine ratings were reduced by 50% after the use of cannabinoid-based medicine; with cannabinoids in their concentrated form (oil) being related to larger reductions in headache than flower form.

The body of evidence to support the benefit of cannabinoid-based medicine is beginning to grow and we look forward to seeing more studies like this come forward.

Read the full article here.

New Jersey Governor, Phil Murphy expands medical marijuana program: NBC

A renaissance is coming to New Jersey’s long embattled medical marijuana program. 

Democratic Gov. Phil Murphy announced a long list of reforms this morning, including lowering fees for patients and caregivers, adding five approved medical conditions and proposing legislation to increase monthly product limit for patients.

Patients receiving hospice care would be eligible for an unlimited supply of cannabis. Effective immediately, patients suffering from anxiety, migraines, Tourette’s syndrome, chronic pain related to musculoskeletal disorders, and chronic visceral pain will be eligible for the medical cannabis program.

Murphy added that he would like to eventually see opioid addiction added to the growing list of approved conditions. He called cannabis “an offensive weapon” to the growing crisis.

Full article